Scott VanderMeer is a Managing Partner and co-founder of International Infusion Holdings, International Infusion Advisors, and Infusion 51a LP. Scott is also the CEO, CFO, Co-founder, and Director of Vivacitas Oncology Inc., a clinical stage biopharmaceutical company. In addition, Scott served as the CFO of Theralink Technologies, Inc., where Scott focused on restructuring the company and increasing revenue. Scott has a Bachelor's Degree in Marketing, Business, Management, Marketing, and Related Support Services, and a Master of Business Administration (MBA) with a concentration in Real Estate from the University of Illinois Chicago.
Sign up to view 1 direct report
Get started